Related Experiment Video
Updated: Jul 12, 2025
13:54
Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
11.0K
Selenadiazole Inhibited Adenovirus-Induced Apoptosis through the Oxidative-Damage-Mediated Bcl-2/Stat 3/NF-κB
Xia Liu1, Jia Lai1, Jingyao Su1
1Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510120, China.
Pharmaceuticals (Basel, Switzerland)
|October 28, 2023
Summary
Researchers discovered selenadiazole effectively combats human adenovirus type 7 (HAdV7) pneumonia. This novel antiviral agent inhibits viral-induced apoptosis and oxidative stress, offering a promising new treatment for adenovirus infections.
Area of Science:
- Virology
- Drug Discovery
- Molecular Biology
Background:
- Human adenovirus type 7 (HAdV7) causes severe pneumonia with limited treatment options.
- Antiviral drug development for adenoviruses faces significant challenges.
Purpose of the Study:
- To evaluate the antiviral potential of selenadiazole against HAdV7.
- To investigate selenadiazole's mechanism in mitigating adenovirus-induced lung injury.
Main Methods:
- In vitro experiments assessing selenadiazole's inhibition of adenovirus-mediated apoptosis and oxidative damage.
- In vivo studies in mice to evaluate selenadiazole's effect on apoptosis signaling pathways (Bcl-2/Stat3/NF-κB) and lung injury.
Main Results:
- Selenadiazole demonstrated significant antiviral activity against HAdV7 in vitro.
- Selenadiazole inhibited adenovirus-induced mitochondrial oxidative damage and apoptosis.
- In vivo, selenadiazole attenuated HAdV7-induced pneumonia and lung injury by modulating apoptotic pathways.
Conclusions:
- Selenadiazole presents a novel therapeutic candidate for HAdV7 infections.
- Targeting adenovirus-mediated oxidative stress and apoptosis with selenadiazole shows therapeutic promise.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
01:24Caspases
12.5K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.5K
01:17The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K